Covalent Peptide LSD1 Inhibitor Specifically Recognizes Cys360 in the Enzyme-Active Region
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Covalent Peptide LSD1 Inhibitor Specifically Recognizes Cys360 in the Enzyme-Active Region
Authors
Keywords
-
Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume -, Issue -, Pages -
Publisher
American Chemical Society (ACS)
Online
2023-11-04
DOI
10.1021/acs.jmedchem.3c01549
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phenothiazine-Based LSD1 Inhibitor Promotes T-Cell Killing Response of Gastric Cancer Cells
- (2023) Xing-Jie Dai et al. Journal of Medicinal Chemistry
- Design and Evaluation of a Novel Peptide–Drug Conjugate Covalently Targeting SARS-CoV-2 Papain-like Protease
- (2022) Na Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of LSD1 with bomedemstat sensitizes small cell lung cancer to immune checkpoint blockade and T cell killing
- (2022) Joseph B. Hiatt et al. CLINICAL CANCER RESEARCH
- Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLC
- (2022) Evelyn M. Nguyen et al. Journal of Thoracic Oncology
- Advances in covalent drug discovery
- (2022) Lydia Boike et al. NATURE REVIEWS DRUG DISCOVERY
- Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1
- (2021) Xing-Jie Dai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Identification of Potent Lysine-Specific Demethylase 1 Inhibitor Peptides and Temporary Cyclization to Enhance Proteolytic Stability and Cell Growth-Inhibitory Activity
- (2021) Hiroki Kitagawa et al. JOURNAL OF MEDICINAL CHEMISTRY
- LSD1 silencing contributes to enhanced efficacy of anti-CD47/PD-L1 immunotherapy in cervical cancer
- (2021) Shengjie Xu et al. Cell Death & Disease
- Targeting LSD1 suppresses stem cell-like properties and sensitizes head and neck squamous cell carcinoma to PD-1 blockade
- (2021) Yong Han et al. Cell Death & Disease
- LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade
- (2021) Yi Liu et al. Nature Communications
- Macrocyclic Peptides Uncover a Novel Binding Mode for Reversible Inhibitors of LSD1
- (2020) Jie Yang et al. ACS Omega
- Selective Covalent Targeting of Anti‐Apoptotic BFL‐1 by a Sulfonium Tethered Peptide
- (2020) Na Liu et al. CHEMBIOCHEM
- Epigenetic Reexpression of Hemoglobin F Using Reversible LSD1 Inhibitors: Potential Therapies for Sickle Cell Disease
- (2020) Steven Holshouser et al. ACS Omega
- Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1)
- (2020) Toufike Kanouni et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phase I, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of GSK2879552 in Relapsed/Refractory SCLC
- (2019) Todd M. Bauer et al. Journal of Thoracic Oncology
- LSD1/KDM1A inhibitors in clinical trials: advances and prospects
- (2019) Yuan Fang et al. Journal of Hematology & Oncology
- Histone H3 peptides incorporating modified lysine residues as lysine-specific demethylase 1 inhibitors
- (2018) Taeko Kakizawa et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia
- (2018) Tamara Maes et al. CANCER CELL
- LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
- (2018) Wanqiang Sheng et al. CELL
- Cyclic peptide inhibitors of lysine-specific demethylase 1 with improved potency identified by alanine scanning mutagenesis
- (2018) Isuru R. Kumarasinghe et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
- (2018) Jean-Charles Soria et al. NEW ENGLAND JOURNAL OF MEDICINE
- FLI-06 suppresses proliferation, induces apoptosis and cell cycle arrest by targeting LSD1 and Notch pathway in esophageal squamous cell carcinoma cells
- (2018) Zhaoming Lu et al. BIOMEDICINE & PHARMACOTHERAPY
- Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade
- (2018) Ye Qin et al. ONCOGENE
- Pharmacological Inhibition of LSD1 for Cancer Treatment
- (2018) Guan-Jun Yang et al. MOLECULES
- Tying up tranylcypromine: Novel selective histone lysine specific demethylase 1 (LSD1) inhibitors
- (2017) Yue-Yang Ji et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation
- (2017) Y He et al. ONCOGENE
- Identification of SNAIL1 Peptide-Based Irreversible Lysine-Specific Demethylase 1-Selective Inactivators
- (2016) Yukihiro Itoh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lateral Thinking: How Histone Modifications Regulate Gene Expression
- (2016) Moyra Lawrence et al. TRENDS IN GENETICS
- Protein Recognition by Short Peptide Reversible Inhibitors of the Chromatin-Modifying LSD1/CoREST Lysine Demethylase
- (2013) Marcello Tortorici et al. ACS Chemical Biology
- Synthesis and Evaluation of Novel Cyclic Peptide Inhibitors of Lysine-Specific Demethylase 1
- (2013) Isuru R. Kumarasinghe et al. ACS Medicinal Chemistry Letters
- Azalysine Analogues as Probes for Protein Lysine Deacetylation and Demethylation
- (2012) Blair C. R. Dancy et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Novel Histone Demethylase LSD1 Inhibitors Selectively Target Cancer Cells with Pluripotent Stem Cell Properties
- (2011) J. Wang et al. CANCER RESEARCH
- Regulation of chromatin by histone modifications
- (2011) Andrew J Bannister et al. CELL RESEARCH
- The Checkpoints of Viral Gene Expression in Productive and Latent Infection: the Role of the HDAC/CoREST/LSD1/REST Repressor Complex
- (2011) B. Roizman JOURNAL OF VIROLOGY
- Molecular Mimicry and Ligand Recognition in Binding and Catalysis by the Histone Demethylase LSD1-CoREST Complex
- (2011) Riccardo Baron et al. STRUCTURE
- Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers
- (2010) Shinya Hayami et al. INTERNATIONAL JOURNAL OF CANCER
- Histone Demethylase LSD1 Regulates Neural Stem Cell Proliferation
- (2010) G. Sun et al. MOLECULAR AND CELLULAR BIOLOGY
- LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast Cancer
- (2009) Yan Wang et al. CELL
- Identification of Cell-Active Lysine Specific Demethylase 1-Selective Inhibitors
- (2009) Rie Ueda et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Involvement of Histone Demethylase LSD1 in Blimp-1-Mediated Gene Repression during Plasma Cell Differentiation
- (2009) S.-T. Su et al. MOLECULAR AND CELLULAR BIOLOGY
- LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis
- (2009) X. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation
- (2008) Jing Wang et al. NATURE GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search